Audited Results of Bliss GVS Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Income	667.20	605.46	598.34	636.36	465.51
Manufacturing Expenses	9.76	8.81	5.80	7.09	6.99
Personnel Expenses	99.42	82.59	72.54	65.06	58.61
Selling Expenses	1.61	0.99	0.50	0.14	0.17
Administrative Expenses	118.73	106.43	114.45	110.92	54.98
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	575.62	498.29	508.18	527.16	374.05
Operating Profit	91.59	107.17	90.16	109.20	91.46
Other Recurring Income	36.22	33.50	50.77	32.63	17.68
Adjusted PBDIT	127.80	140.67	140.92	141.83	109.14
Financial Expenses	6.58	5.81	10.06	4.32	4.19
Depreciation	27.05	23.52	15.17	13.85	13.76
Other Write offs	0	0	0	0	0
Adjusted PBT	94.17	111.34	115.69	123.66	91.19
Tax Charges	25.20	19.61	30.21	33.74	23.69
Adjusted PAT	68.97	91.73	85.48	89.92	67.50
Non Recurring Items	-0.56	-41.24	-0.67	3.05	0.52
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	68.97	50.64	85.48	92.66	67.50
Equity Dividend	5.25	5.21	5.19	5.18	5.16
Preference Dividend	0	0	0	0	0
Retained Earnings	955.74	891.46	844.96	764.02	676.22

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article